On Mar 14, 2022 Iaso Therapeutics closed a Grant round and raised $978,597 from National Science Foundation, featuring lead investors National Science Foundation.

About the company: Iaso Therapeutics is located at United States, North America.
“Iaso Therapeutics is focused on development of novel technologies for next generation vaccines including vaccines targeting cancer & infectious diseases.”

Company website: http://www.iasotherapeutics.com